Breaking News

OmniComm, Veeda in Preferred Program Pact

Will run first study using the TrialMaster EDC suite

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Veeda Clinical Research has joined OmniComm Systems CRO Preferred Program, and has signed an agreement to run its first study. The Phase I oncology trial will use the TrialMaster EDC suite to manage data collection, submission, and medical coding needs. The CRO program offers a dedicated, hosted environment, sales and marketing support, as well as training.   “We specifically selected TrialMaster due to their experience and expertise in conducting Oncology trials,” said Sharon Jameson, vice pres...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters